Sidley represented Nous Research, an artificial intelligence (AI) company focused on developing open-source AI models and agents, in its US$90 million Series B financing at a valuation of US$1.5 ...
Sidley represented Analog Devices in the issuance of US$3 billion in aggregate principal amount of senior notes. The offering consisted of US$500 million of 5.100% senior notes due 2029, US$500 ...
Sidley is representing GE HealthCare (Nasdaq: GEHC) in its US$945 million acquisition of radiopharmaceutical company SOFIE Biosciences. With SOFIE Biosciences’ U.S. network of 15 Contract ...
Sidley is representing global radiopharmaceutical company Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX) in its US$1.65 billion acquisition of ITM Isotope Technologies Munich SE, a ...
Sidley advised Galvanize as lead financier in US$70 million of project debt financing for AMP, an AI-powered waste and recycling company, to fund construction of a new sortation facility and organics ...
The Hollywood Reporter has named Matthew Thompson and Rollin Ransom to its 2026 “Power Music Lawyers” list, recognizing attorneys behind significant transactions, disputes, and other developments ...
Her Justice has recognized Juan A. Arteaga, Adriana Bones Ortega, Thomas M. Cramer, and Martha O. Tabor with its 2026 “Legal Team Award” at the Commitment to Justice award ceremony. The Sidley team ...
Sidley represented Invenergy, North America’s largest privately held developer, owner, and operator of power infrastructure, in the formation of its strategic equity partnership with HA Sustainable ...
Sidley represented SlateView Capital in connection with the acquisition of Parkview Estates by its joint venture with an institutional partner. Completed in 2021, Parkview Estates is a 151-unit ...
Sidley represented Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage biotechnology company developing next-generation therapeutics for difficult-to-treat cancers, in its underwritten public ...
Sidley represented Jiangsu Nhwa Pharmaceutical Co. in an agreement with newly formed biotechnology company Somnivera for the ex-China rights to a clinical-stage sleep disorder drug. Under the ...
Chicago – Sidley is pleased to announce that Ryan McNish has joined the firm as a partner in its Investment Funds practice group in the firm’s office in Chicago. He joins from Kirkland & Ellis LLP, ...